The global anticoagulants market exhibited moderate growth during 2015-2020.
Looking forward, the analyst expects the market to grow at a CAGR of around 10% during 2021-2026. Keeping in mind the uncertainties of COVID-19, we are continuously tracking and evaluating the direct as well as the indirect influence of the pandemic. These insights are included in the report as a major market contributor.
Blood clots form when blood thickens and forms a semi-solid mass in any part of the body. This causes serious problems, such as stroke, heart attack, pulmonary embolism, transient ischemic attacks, and deep vein thrombosis (DVT). As a result, doctors around the world are prescribing anticoagulant drugs to people who are at a high risk of clot formation. These drugs help in thinning blood, preventing or reducing blood clotting, and prolonging the clotting time. They are usually available in capsule or tablet form, including warfarin, rivaroxaban, dabigatran, and apixaban.
Anticoagulants Market Trends: Recent research indicates that hypercoagulability in individuals affected by the coronavirus disease (COVID-19) pandemic can be one of the leading causes of mortality worldwide. As a result, its surging cases are positively influencing the demand for anticoagulant drugs to treat the thrombotic condition among critically ill or hospitalized patients. Moreover, certain risk factors, such as extended sitting, smoking, trauma, blood disorders, and autoimmune diseases, can cause blood clotting in different parts of the body. This, in confluence with the increasing prevalence of human immunodeficiency virus (HIV), hepatitis C, Lyme disease, obesity, cancer, and chronic inflammation, represents another significant factor strengthening the growth of the market. Apart from this, the growing aging population across the globe is resulting in the escalating demand for surgical services. Surgeries often require prolonged bed rest, which, in turn, increases the risk of blood clotting and the overall sales of anticoagulant drugs. Furthermore, the improving diagnosis rates and the escalating demand for target therapeutics are fueling the market growth. The emergence of online pharmacies is also driving the demand for anticoagulant drugs around the world.
Key Market Segmentation: the analyst provides an analysis of the key trends in each sub-segment of the global anticoagulants market, along with forecasts at the global, regional and country level from 2021-2026. Our report has categorized the market based on drug class, route of administration, distribution channel and application.
Breakup by Drug Class: Novel Oral Anticoagulants (NOACs) Heparin and Low Molecular Weight Heparin (LMWH) Vitamin K Antagonist Others
Breakup by Route of Administration: Oral Anticoagulant Injectable Anticoagulant
Breakup by Distribution Channel: Hospital Pharmacies Retail Pharmacies Online Stores Others
Breakup by Application: Atrial Fibrillation and Heart Attack Stroke Deep Vein Thrombosis (DVT) Pulmonary Embolism (PE) Others
Breakup by Region: North America United States Canada Asia-Pacific China Japan India South Korea Australia Indonesia Others Europe Germany France United Kingdom Italy Spain Russia Others Latin America Brazil Mexico Others Middle East and Africa
Competitive Landscape: The competitive landscape of the industry has also been examined along with the profiles of the key players being Alexion Pharmaceuticals Inc, Aspen Holdings, Bayer AG, Boehringer Ingelheim International GmbH, Bristol-Myers Squibb Company, Daiichi Sankyo Company Limited, Dr. Reddy’s Laboratories Ltd, GlaxoSmithKline plc, Johnson & Johnson Private Limited, Pfizer Inc. and Sanofi. Key Questions Answered in This Report: How has the global anticoagulants market performed so far and how will it perform in the coming years? What has been the impact of COVID-19 on the global anticoagulants market? What are the key regional markets? What is the breakup of the market based on the drug class? What is the breakup of the market based on the route of administration? What is the breakup of the market based on the distribution channel? What is the breakup of the market based on the application? What are the various stages in the value chain of the industry? What are the key driving factors and challenges in the industry? What is the structure of the global anticoagulants market and who are the key players? What is the degree of competition in the industry?
Our reports have been used by over 10K customers, including:
The frozen tissues samples market is projected to reach US$ 105,045.91 Thousand by 2028 from US$ 44,399.07 Thousand in 2021; it is estimated to grow at a CAGR of 13.1% during 2021-2028. The report highlights trends prevailing in the market and the factors driving it.The growth of the frozen tissues samples market is attributed to the...
The global alopecia treatment market exhibited moderate growth during 2015-2020. Looking forward, the analyst expects the market to grow at a CAGR of around 5% during 2021-2026. Alopecia, also known as hair loss, is an autoimmune skin disease affecting the growth of healthy hair follicles on the scalp, face,...
The global anti-rheumatics market exhibited moderate growth during 2015-2020. Looking forward, the analyst expects the market to grow at a CAGR of around 4% during 2021-2026. Keeping in mind the uncertainties of COVID-19, we are continuously tracking and evaluating the direct as well as the indirect influence of the...
The anatomic pathology market is projected to reach USD 49.1 billion by 2026 from USD 35.1 billion in 2021, at a CAGR of 7.0%. The growth of the anatomic pathology market is majorly driven by the high incidence of cancer and other target diseases, recommendations for cancer screening, availability of reimbursement, and the growing focus on...
Proton Therapy Market Size, Share, Global Forecast 2022-2027, Industry Trends, Impact of COVID-19, Opportunity Company Analysis Proton therapy is a type of radiation called proton beam radiation therapy it is safer and more effective than conventional radiation therapy for adults with advanced stages cancer. Since,...
The anatomic pathology market is projected to reach US$ 33,145.78 million by 2028 from US$ 21,488. 41 million in 2021; it is estimated to grow at a CAGR of 6.4% from 2021 to 2028. Factors such as increase in the prevalence of cancer and other diseases, and growing focus on personalized medicines. However, the lack of skilled professionals...
269 pages •
By The Business Research Company
• Aug 2021
Anatomic Pathology Equipment and Consumables Market Opportunities And Strategies To 2030: COVID-19 Growth And Change provides the strategists, marketers and senior management with the critical information they need to assess the global anatomic pathology equipment and consumables market as it emerges from the COVID 19 shut down. Description: Where...
Interleukin 1 (IL1) - Drugs in Development, 2021 Summary According to the recently published report ’Interleukin 1 - Drugs in Development, 2021’; Interleukin 1 (IL1) pipeline Target constitutes close to 36 molecules. Out of which approximately 35 molecules are developed by companies and remaining...
The global immunofluorescence assays market is projected to reach USD 3.5 billion by 2026 from USD 2.6 billion in 2021, at a CAGR of 6.0% during the forecast period. The growth in this market is primarily attributed to the increasing prevalence of chronic diseases and rising R&D spending & healthcare expenditure. Emerging markets are expected...
An organ-on-a-chip is a microfluidic cell culture device that contains continuously perfused chambers. This chip develops a narrow channel for the blood and airflow in organs, such as the lung, gut, liver, heart, and other organs. Such devices produce multiple levels of tissue and organ functionalities, which are not feasible using conventional...
Cause-Specific Mortality Rate
You can change your Cookie Settings at any time but parts of our site will not function correctly without them.